Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
- Published In:
- Antimicrobial agents and chemotherapy, 49(7), 2606-11 (2005)
- Authors:
- Morgan, Sheila M, O'connor, Paula M(3), Cotter, Paul D, Ross, R Paul, Hill, Colin
- Database ID:
- RPEP-01070
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01070APA
Morgan, Sheila M; O'connor, Paula M; Cotter, Paul D; Ross, R Paul; Hill, Colin. (2005). Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.. Antimicrobial agents and chemotherapy, 49(7), 2606-11.
MLA
Morgan, Sheila M, et al. "Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.." Antimicrobial agents and chemotherapy, 2005.
RethinkPeptides
RethinkPeptides Research Database. "Sequential actions of the two component peptides of the lant..." RPEP-01070. Retrieved from https://rethinkpeptides.com/research/morgan-2005-sequential-actions-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.